Artelo Biosciences ARTL
NASDAQ ARTL
$3.68 -0.15 (-3.92%)
At close: Oct 2, 2026 · 4:00 PM EDT

Artelo Biosciences (ARTL) Non Operating Interest Expenses (2017 - 2025)

Updated

Artelo Biosciences' Non Operating Interest Expenses was $11,000 in Q4 2025, down 90.1% from the prior quarter.

Analysis

Artelo Biosciences (ARTL) Non Operating Interest Expenses (2017 - 2025) Analysis & Trends

For FY2025, Non Operating Interest Expenses at Artelo Biosciences came in at $194,000.

  • Non Operating Interest Expenses shows a three-year compound annual growth rate of 238.5% (FY2022 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $5,000 in FY2022.
  • The Q4 2025 figure marks the lowest quarterly Non Operating Interest Expenses since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Artelo Biosciences 76,308.92 -5.06 Mn - 11,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 11,000.00
Sep 30, 2025 111,000.00
Jun 30, 2025 72,000.00
Sep 30, 2022 5,000.00
Aug 31, 2017 177.00
May 31, 2017 907.00
Feb 28, 2017 1,016.00
API Access

Artelo Biosciences Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ARTL&period=max&api_key=YOUR_API_KEY